BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25450212)

  • 1. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity.
    Anjani K; Lhomme M; Sokolovska N; Poitou C; Aron-Wisnewsky J; Bouillot JL; Lesnik P; Bedossa P; Kontush A; Clement K; Dugail I; Tordjman J
    J Hepatol; 2015 Apr; 62(4):905-12. PubMed ID: 25450212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
    Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients.
    D'Incao RB; Tovo CV; Mattevi VS; Borges DO; Ulbrich JM; Coral GP; Ramos MJ; Meinhardt NG
    Obes Surg; 2017 Aug; 27(8):2151-2158. PubMed ID: 28281237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis.
    Cabré N; Luciano-Mateo F; Baiges-Gayà G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; París M; Sabench F; Del Castillo D; López-Miranda J; Menéndez JA; Camps J; Joven J
    Aliment Pharmacol Ther; 2020 Feb; 51(3):374-387. PubMed ID: 31825539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in adipocytokines and cGMP homeostasis in morbid obesity patients reverse after bariatric surgery.
    Felipo V; Urios A; García-Torres ML; El Mlili N; del Olmo JA; Civera M; Ortega J; Ferrandez A; Martínez-Valls J; Cassinello N; Montoliu C
    Obesity (Silver Spring); 2013 Feb; 21(2):229-37. PubMed ID: 23404955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.
    Caballero T; Gila A; Sánchez-Salgado G; Muñoz de Rueda P; León J; Delgado S; Muñoz JA; Caba-Molina M; Carazo A; Ruiz-Extremera A; Salmerón J
    Histol Histopathol; 2012 Apr; 27(4):459-66. PubMed ID: 22374723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?
    Birerdinc A; Younossi Z
    J Hepatol; 2015 Apr; 62(4):761-2. PubMed ID: 25602593
    [No Abstract]   [Full Text] [Related]  

  • 17. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
    Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
    Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
    Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
    Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?
    Helling TS; Helzberg JH; Nachnani JS; Gurram K
    Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.